المؤلفون: Kotz, K., Krigel, R. L.

المساهمون: Seeber, Siegfried, editor^Aff1, Schütte, Jochen, editor^Aff1

المصدر: Therapiekonzepte Onkologie. :754-762

المؤلفون: Kotz, K., Krigel, R. L.

المساهمون: Seeber, Siegfried, editor^Aff1, Schütte, Jochen, editor^Aff1

المصدر: Therapiekonzepte Onkologie. :382-388

المؤلفون: Muggia, F. M.^Aff4, Dancis, A.^Aff4, Odajnyk, C.^Aff4, Raphael, B.^Aff4, Wernz, J. C.^Aff4, Krigel, R. L.^Aff4, Laubenstein, L. J.^Aff4, Knowles, D. M.^Aff4

المساهمون: Cavalli, Franco, editor^Aff1, Bonadonna, G., editor^Aff2, Rozencweig, Marcel, editor^Aff3

المصدر: Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances : Proceedings of the Second International Conference on Malignant Lymphomas, Lugano, Switzerland, June 13 – 16, 1984. 32:251-260

المؤلفون: Krigel, R. L., Slywotzky, C. M., Lonberg, M., Green, M. D., Andes, W. A., Kempf, R., Gupta, S., Grace, W., Spiegel, R. J., Muggia, F. M., Grossberg, H.

المصدر: Journal of Immunotherapy; Aug1988, Vol. 7 Issue 4, p359-364, 6p

المؤلفون: O'Neill, B P, Wang, C H, O'Fallon, J R, Colgan, J P, Earle, J D, Krigel, R L, Brown, L D, McGinnis, W J

المصدر: Neuro-Oncology; July 1999, Vol. 1 Issue: 3 p196-203, 8p

المؤلفون: O'Neill, B. P., Wang, C.-H., O'Fallon, J. R., Colgan, J. D., Earle, J. D., Krigel, R. L., Brown, L. D., McGinnis, W. L.

المصدر: International Journal of Radiation, Oncology, Biology, Physics; 1999, Vol. 43 Issue: 3 p559-564, 6p

المؤلفون: Krigel, R L

المصدر: Annals of Internal Medicine; 7/15/89, Vol. 111 Issue 2, p185-187, 3p

مصطلحات موضوعية: THERAPEUTIC use of interferons, AIDS, KAPOSI'S sarcoma, DISEASE complications

المؤلفون: Tester WJ; Albert Einstein Cancer Center, Philadelphia, PA 19141, USA. testerb@aehn2.einstein.edu, Kim KM, Krigel RL, Bonomi PD, Glick JH, Asbury RF, Kirkwood JM, Blum RH, Schiller JH

المصدر: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 1999 Sep; Vol. 25 (3), pp. 199-206.

نوع المنشور: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print Cited Medium: Print ISSN: 0169-5002 (Print) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Carcinoma, Non-Small-Cell Lung/*drug therapy , Interferon-beta/*therapeutic use , Interleukin-2/*therapeutic use , Lung Neoplasms/*drug therapy, Adenocarcinoma/drug therapy ; Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Adult ; Aged ; Antineoplastic Agents/administration & dosage ; Carcinoma, Non-Small-Cell Lung/mortality ; Carcinoma, Non-Small-Cell Lung/pathology ; Carcinoma, Squamous Cell/drug therapy ; Carcinoma, Squamous Cell/mortality ; Carcinoma, Squamous Cell/pathology ; Drug Therapy, Combination ; Female ; Humans ; Injections, Intravenous ; Interferon-beta/administration & dosage ; Interleukin-2/administration & dosage ; Lung Neoplasms/mortality ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Staging ; Retrospective Studies ; Survival Rate ; Treatment Outcome

المؤلفون: O'Neill BP; Department of Neurology, Mayo Clinic/Foundation, Rochester, MN 55905, USA., O'Fallon JR, Earle JD, Colgan JP, Brown LD, Krigel RL

المصدر: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 1995 Oct 15; Vol. 33 (3), pp. 663-73.

نوع المنشور: Clinical Trial; Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print Cited Medium: Print ISSN: 0360-3016 (Print) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE

مواضيع طبية MeSH: Cranial Irradiation*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Brain Neoplasms/*drug therapy , Brain Neoplasms/*radiotherapy , Lymphoma, Non-Hodgkin/*drug therapy , Lymphoma, Non-Hodgkin/*radiotherapy, Adult ; Age Factors ; Aged ; Brain Neoplasms/mortality ; Cause of Death ; Combined Modality Therapy ; Cyclophosphamide/administration & dosage ; Cytarabine/administration & dosage ; Doxorubicin/administration & dosage ; Female ; Follow-Up Studies ; Humans ; Lymphoma, Non-Hodgkin/mortality ; Male ; Middle Aged ; Prednisolone/administration & dosage ; Vincristine/administration & dosage

SCR Protocol: VAP-cyclo protocol

المؤلفون: Negendank WG; Department of Nuclear Magnetic Resonance and Medical Spectroscopy, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA., Padavic-Shaller KA, Li CW, Murphy-Boesch J, Stoyanova R, Krigel RL, Schilder RJ, Smith MR, Brown TR

المصدر: Cancer research [Cancer Res] 1995 Aug 01; Vol. 55 (15), pp. 3286-94.

نوع المنشور: Journal Article; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Print ISSN: 0008-5472 (Print) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Non-Hodgkin/*metabolism, 2,3-Diphosphoglycerate ; Adult ; Aged ; Diphosphates/metabolism ; Diphosphoglyceric Acids/metabolism ; Esters/metabolism ; Ethanolamines/metabolism ; Female ; Humans ; Magnetic Resonance Spectroscopy ; Male ; Middle Aged ; Phosphatidylethanolamines/metabolism ; Phosphocreatine/metabolism ; Phosphorylcholine/metabolism